News | Radiation Therapy | April 29, 2019

Novel Software Improves Accuracy of Radiation Therapy for Pediatric Cancer Treatment

Study examines use of Sun Nuclear’s PerFraction software to automate adjustment of treatment planning

Novel Software Improves Accuracy of Radiation Therapy for Pediatric Cancer Treatment

April 29, 2019 — A new report by Arthur Olch, Ph.D., highlights use of specialized software at Children’s Hospital Los Angeles (CHLA) that could advance treatment accuracy of radiation oncology for pediatric cancer patients.

During radiation therapy, patient position must be stable from session to session to ensure radiation beams are properly targeting the tumor. For this reason, X-ray images are taken before each treatment. Radiation therapists can use this information to reorient the patient so that the position is exactly the same each time. Doctors at CHLA are taking this already rigorous process one step further. From early in its development Olch, a radiation physicist, has been evaluating the use of new software to advance quality assurance in radiation therapy. In a recent publication, he highlights the use of this technological advance to aid in the treatment of pediatric cancers.

Radiation therapy uses a beam of targeted X-rays that kill cancer cells over the course of treatment. After the beam passes through the patient, it is captured on an imaging panel. Olch and his team make use of the information carried by these beams, called exit images, using the automated software. These images contain important information about the exact dose being delivered to the tumor and surrounding tissues and can be compared to the planned doses. Up to 20 images might be generated per treatment session. With treatments occurring every day for several weeks, this makes for an unwieldy amount of data to manually process. Now, radiation oncology staff have a tool that will do this in seconds. The program automates not only image capture but also analysis.

Analyzing these images provides new information that allows further fine tuning of the radiation beams and patient position from session to session. This, said Olch, gives radiation oncologists more information that can be used to account for anatomy changes in real time. "If a patient gains or loses weight, their dimensions change" he said. "Likewise, as the tumor shrinks, radiation beams need to take a different trajectory."

Adjustments are routinely made as a standard of care, but by utilizing the latest technological advances, CHLA radiation oncologists are redefining this standard. "We have a very comprehensive quality assurance strategy," said Olch, "and this software is an important addition to our already high standard of care."

Olch is also a professor of clinical radiation oncology at the University of Southern California (USC). He co-authored the publication with Kyle O'Meara and Kenneth Wong, M.D. Olch provides consulting services to Sun Nuclear Corp., who provided PerFraction software but did not fund the study.

For more information: www.advancesradonc.org

Reference

1. Olch A.J., O’Meara K., Wong K. First Report of the Clinical use of a Commercial Automated System for Daily Patient QA using EPID Exit Images. Advances in Radiation Oncology, published online April 12, 2019. https://doi.org/10.1016/j.adro.2019.04.001

Related Content

Early diagnosis of cancer is one of the highest-priority problem for the healthcare system, because it is critical for overall treatment success and saving patients' lives. Diffusion-weighted magnetic resonance imaging (DWI) may be used to detect a malignancy in various tissues and organs. It has the advantage of providing insight into the diffusion of water molecules in body tissues without exposing patients to radiation.

DWI of the phantom with polyvinylpyrrolidone (PVP) solutions (b value 500 s/mm2). Image courtesy of Kristina Sergunova et al.

News | Magnetic Resonance Imaging (MRI) | June 02, 2020
June 2, 2020 — Early diagnosis of cancer is one of the highest-priority problem for the healthcare system, because it
The FDA has approved Lilly’s TAUVID (flortaucipir F 18 injection), a radioactive diagnostic agent, for PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease

Getty Images

News | Contrast Media | June 01, 2020
June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for...
MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

 

News | Radiation Therapy | June 01, 2020
June 1, 2020 — RefleXion Medical, a therape
Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Feature | Proton Therapy | May 27, 2020 | By Minesh Mehta, M.D.
Radiation therapy has advanced significantly in the last few decades as a result of a continued technological revolut
Technology becomes a state-of-the-art tool when it gets exposed to a structure that constantly tests it and allows it to evolve.

Technology becomes a state-of-the-art tool when it gets exposed to a structure that constantly tests it and allows it to evolve. Getty Images

Feature | Oncology Information Management Systems (OIMS) | May 27, 2020 | By Reshu Gupta
In the history of medicine, researchers have found cures for many diseases, but cancer has been elusive.
Off-site imaging companies are playing a key role in the fight against COVID-19
Feature | Coronavirus (COVID-19) | May 26, 2020 | By Sean Zahniser
After the worst of the COVID-19 pandemic has pas
a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the xy and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.

News | Breast Imaging | May 26, 2020
May 26, 2020 — Breast cancer is the most common cancer in women.
A new technique developed by researchers at UC Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The team created a probe that generates two magnetic resonance signals that suppress each other until they reach the target, at which point they both increase contrast between the tumor and surrounding tissue

A new technique developed by researchers at UC Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The team created a probe that generates two magnetic resonance signals that suppress each other until they reach the target, at which point they both increase contrast between the tumor and surrounding tissue. Image courtesy of Xiandoing Xue, UC Davis

News | Magnetic Resonance Imaging (MRI) | May 26, 2020
May 26, 2020 — Researchers at the University of California, Davis offers a...